Attendo AB (publ) (ATT.ST)
SEK 51.8
(1.77%)
SEK 51.8
(1.77%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 376 Million SEK | 954.55% |
| 2022 | -44 Million SEK | -178.57% |
| 2021 | 56 Million SEK | 106.19% |
| 2020 | -904 Million SEK | -1216.05% |
| 2019 | 81 Million SEK | -92.15% |
| 2018 | 1.03 Billion SEK | 51.76% |
| 2017 | 680 Million SEK | 4.78% |
| 2016 | 649 Million SEK | 126.92% |
| 2015 | 286 Million SEK | 8.75% |
| 2014 | 263 Million SEK | -27.55% |
| 2013 | 363 Million SEK | 52.07% |
| 2012 | 238.7 Million SEK | 217.59% |
| 2011 | -203 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 44 Million SEK | -30.16% |
| 2024 Q3 | 235 Million SEK | 434.09% |
| 2024 Q1 | 63 Million SEK | 8.62% |
| 2023 Q2 | 60 Million SEK | 114.29% |
| 2023 Q1 | 28 Million SEK | 163.64% |
| 2023 Q3 | 230 Million SEK | 283.33% |
| 2023 FY | 376 Million SEK | 954.55% |
| 2023 Q4 | 58 Million SEK | -74.78% |
| 2022 FY | -44 Million SEK | -178.57% |
| 2022 Q4 | -44 Million SEK | -146.32% |
| 2022 Q3 | 95 Million SEK | 250.79% |
| 2022 Q2 | -63 Million SEK | -96.88% |
| 2022 Q1 | -32 Million SEK | -255.56% |
| 2021 Q1 | -10 Million SEK | -433.33% |
| 2021 Q2 | -19 Million SEK | -90.0% |
| 2021 Q3 | 94 Million SEK | 594.74% |
| 2021 Q4 | -9 Million SEK | -109.57% |
| 2021 FY | 56 Million SEK | 106.19% |
| 2020 Q3 | 64 Million SEK | 106.56% |
| 2020 Q4 | 3 Million SEK | -95.31% |
| 2020 FY | -904 Million SEK | -1216.05% |
| 2020 Q1 | 3 Million SEK | 107.5% |
| 2020 Q2 | -976 Million SEK | -32633.33% |
| 2019 Q1 | 66 Million SEK | -89.41% |
| 2019 Q2 | -39 Million SEK | -159.09% |
| 2019 Q3 | 94 Million SEK | 341.03% |
| 2019 FY | 81 Million SEK | -92.15% |
| 2019 Q4 | -40 Million SEK | -142.55% |
| 2018 FY | 1.03 Billion SEK | 51.76% |
| 2018 Q4 | 623 Million SEK | 198.09% |
| 2018 Q3 | 209 Million SEK | 194.37% |
| 2018 Q2 | 71 Million SEK | -44.96% |
| 2018 Q1 | 129 Million SEK | -4.44% |
| 2017 Q2 | 141 Million SEK | -22.1% |
| 2017 FY | 680 Million SEK | 4.78% |
| 2017 Q3 | 223 Million SEK | 58.16% |
| 2017 Q4 | 135 Million SEK | -39.46% |
| 2017 Q1 | 181 Million SEK | 19.87% |
| 2016 Q1 | 128 Million SEK | 1522.22% |
| 2016 FY | 649 Million SEK | 126.92% |
| 2016 Q3 | 224 Million SEK | 53.42% |
| 2016 Q2 | 146 Million SEK | 14.06% |
| 2016 Q4 | 151 Million SEK | -32.59% |
| 2015 FY | 286 Million SEK | 8.75% |
| 2015 Q4 | -9 Million SEK | -104.95% |
| 2015 Q1 | 57 Million SEK | 303.57% |
| 2015 Q2 | 56 Million SEK | -1.75% |
| 2015 Q3 | 182 Million SEK | 225.0% |
| 2014 Q3 | 163 Million SEK | 0.0% |
| 2014 FY | 263 Million SEK | -27.55% |
| 2014 Q4 | -28 Million SEK | -117.18% |
| 2013 FY | 363 Million SEK | 52.07% |
| 2012 FY | 238.7 Million SEK | 217.59% |
| 2011 FY | -203 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Ambea AB (publ) | 455 Million SEK | 17.363% |
| Humana AB (publ) | 176 Million SEK | -113.636% |
| ProstaLund AB (publ) | -17.01 Million SEK | 2310.464% |